Share on StockTwits

Natus Medical (NASDAQ:BABY) posted its quarterly earnings results on Wednesday. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.32 by $0.05, Analyst Ratings.Net reports. The company had revenue of $90.60 million for the quarter, compared to the consensus estimate of $89.12 million.

On a related note, analysts at Raymond James raised their price target on shares of Natus Medical from $21.00 to $25.00 in a research note to investors on Tuesday, November 26th.

Shares of Natus Medical (NASDAQ:BABY) opened at 24.09 on Wednesday. Natus Medical has a one year low of $11.40 and a one year high of $26.47. The stock has a 50-day moving average of $23.28 and a 200-day moving average of $17.63. The company has a market cap of $728.8 million and a price-to-earnings ratio of 39.21.

Natus Medical Incorporated (NASDAQ:BABY) is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.